EXTON, Pa. , Oct. 22, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc.
(NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced participation in the 2024 PDA Universe of Pre-Filled Syringes and Injection Devices Conference in Phoenix , AZ to showcase its leadership and expertise on industry challenges and trends in packaging and containment. "With the rise of biologic drugs, injectables are the fastest growing drug segment today, bringing with it new challenges of complex molecules and treatment requirements," says Atul Patel , Vice President, Delivery Devices at West. "As the market leader, West continues to adapt and expand the performance of high-quality drug delivery packaging and devices to meet the changing needs of patients, regulators, and industry partners.
" At this year's PDA, West will be sharing insights through various posters and a presentation on how leveraging primary container and device platforms can reduce risk and accelerate time-to-market for combination products. Featured Speaking Session: Title: Enabling High-Volume Drug Delivery with a Platform Approach Speaker: Gurmeet Singh , Senior Director, Business Development Date and Time: October 22, 2024 , 10:25- 10:35am PST Featured Posters: Title: Performance of Pre-Filled Syringe Systems at Low Temperature Author: Page McAndrew , Director, Scientific Communications Title: Container Closure Integrity Testing Strategy for Drug-led Combination Products: A.
